Tetravalent Dengue Vaccine: A Review in the Prevention of Dengue Disease
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tetravalent Dengue Vaccine: A Review in the Prevention of Dengue Disease
Authors
Keywords
Protective Efficacy, Dengue Haemorrhagic Fever, Dengue Infection, Dengue Case, DENV Serotypes
Journal
DRUGS
Volume 76, Issue 13, Pages 1301-1312
Publisher
Springer Nature
Online
2016-08-09
DOI
10.1007/s40265-016-0626-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Vaccination Against Dengue: Challenges and Current Developments
- (2016) Bruno Guy et al. Annual Review of Medicine
- Current issues in the economics of vaccination against dengue
- (2016) Yesim Tozan Expert Review of Vaccines
- Cost-effectiveness analysis of dengue vaccination in the Philippines
- (2016) H. Lam et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Integrated analysis of immunogenicity data from 11 dengue vaccine trials across 14 countries at risk for dengue
- (2016) J. Menezes et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- A comparative study on active and passive epidemiological surveillance for dengue in five countries of Latin America
- (2016) Elsa Sarti et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Tetravalent Dengue Vaccine Reduces Symptomatic and Asymptomatic Dengue Virus Infections in Healthy Children and Adolescents Aged 2–16 Years in Asia and Latin America
- (2016) Gustavo Olivera-Botello et al. JOURNAL OF INFECTIOUS DISEASES
- The global economic burden of dengue: a systematic analysis
- (2016) Donald S Shepard et al. LANCET INFECTIOUS DISEASES
- Symptomatic Dengue in Children in 10 Asian and Latin American Countries
- (2016) Maïna L’Azou et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cost-utility analysis of dengue vaccination in a country with heterogeneous risk of dengue transmission
- (2016) Pablo Wenceslao Orellano et al. VACCINE
- Estimating the public health importance of the CYD-tetravalent dengue vaccine: Vaccine preventable disease incidence and numbers needed to vaccinate
- (2016) Bradford D. Gessner et al. VACCINE
- Dengue vaccine: hypotheses to understand CYD-TDV-induced protection
- (2015) Bruno Guy et al. NATURE REVIEWS MICROBIOLOGY
- Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease
- (2015) Sri Rezeki Hadinegoro et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America
- (2015) Luis Villar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Modelling the immunological response to a tetravalent dengue vaccine from multiple phase-2 trials in Latin America and South East Asia
- (2015) Ilaria Dorigatti et al. VACCINE
- Site-specific characterization of envelope protein N-glycosylation on Sanofi Pasteur's tetravalent CYD dengue vaccine
- (2015) Jean Dubayle et al. VACCINE
- Development of the Sanofi Pasteur tetravalent dengue vaccine: One more step forward
- (2015) Bruno Guy et al. VACCINE
- Lot-to-lot consistency of a tetravalent dengue vaccine in healthy adults in Australia: A randomised study
- (2015) Joseph Torresi et al. VACCINE
- Tackling dengue fever: Current status and challenges
- (2015) Taoufik Nedjadi et al. Virology Journal
- Immunogenicity and safety of a tetravalent dengue vaccine in healthy adults in India: A randomized, observer-blind, placebo-controlled phase II trial
- (2015) Anand Prakash Dubey et al. Human Vaccines & Immunotherapeutics
- Epidemiological Trends of Dengue Disease in Colombia (2000-2011): A Systematic Review
- (2015) Luis Angel Villar et al. PLoS Neglected Tropical Diseases
- A Critical Assessment of Vector Control for Dengue Prevention
- (2015) Nicole L. Achee et al. PLoS Neglected Tropical Diseases
- Dengue vaccines: dawning at last?
- (2014) Annelies Wilder-Smith LANCET
- Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial
- (2014) Maria Rosario Capeding et al. LANCET
- Epidemiological Trends of Dengue Disease in Thailand (2000–2011): A Systematic Literature Review
- (2014) Kriengsak Limkittikul et al. PLoS Neglected Tropical Diseases
- Recent Epidemiological Trends of Dengue in the French Territories of the Americas (2000–2012): A Systematic Literature Review
- (2014) Maïna L'Azou et al. PLoS Neglected Tropical Diseases
- Epidemiology of Dengue Disease in the Philippines (2000–2011): A Systematic Literature Review
- (2014) Lulu Bravo et al. PLoS Neglected Tropical Diseases
- Epidemiological Trends of Dengue Disease in Mexico (2000–2011): A Systematic Literature Search and Analysis
- (2014) Héctor Gómez Dantés et al. PLoS Neglected Tropical Diseases
- Epidemiology of Dengue Disease in Malaysia (2000–2012): A Systematic Literature Review
- (2014) Abdul Hamid Mohd-Zaki et al. PLoS Neglected Tropical Diseases
- Immunogenicity and Safety of a Recombinant Tetravalent Dengue Vaccine in Children and Adolescents Ages 9–16 Years in Brazil
- (2013) Gustavo H. Dayan et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- The global distribution and burden of dengue
- (2013) Samir Bhatt et al. NATURE
- Safety and Immunogenicity of a Recombinant Tetravalent Dengue Vaccine in 9–16 Year Olds
- (2013) Luis Á. Villar et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Safety and immunogenicity of a tetravalent dengue vaccine in healthy children aged 2–11 years in Malaysia: A randomized, placebo-controlled, Phase III study
- (2013) Amar-Singh HSS et al. VACCINE
- Potential opportunities and perils of imperfect dengue vaccines
- (2013) Isabel Rodriguez-Barraquer et al. VACCINE
- Persistence of Th1/Tc1 responses one year after tetravalent dengue vaccination in adults and adolescents in Singapore
- (2013) Anke Harenberg et al. Human Vaccines & Immunotherapeutics
- Epidemiological Trends of Dengue Disease in Brazil (2000–2010): A Systematic Literature Search and Analysis
- (2013) Maria Glória Teixeira et al. PLoS Neglected Tropical Diseases
- Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial
- (2012) Arunee Sabchareon et al. LANCET
- Immunogenicity and safety of tetravalent dengue vaccine in 2–11 year-olds previously vaccinated against yellow fever: Randomized, controlled, phase II study in Piura, Peru
- (2012) Claudio F. Lanata et al. VACCINE
- Immunogenicity and safety of recombinant tetravalent dengue vaccine (CYD-TDV) in individuals aged 2–45 years
- (2012) Yee Sin Leo et al. Human Vaccines & Immunotherapeutics
- Priming Effect of Dengue and Yellow Fever Vaccination on the Immunogenicity, Infectivity, and Safety of a Tetravalent Dengue Vaccine in Humans
- (2011) Ming Qiao et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Live-attenuated, tetravalent dengue vaccine in children, adolescents and adults in a dengue endemic country: Randomized controlled phase I trial in the Philippines
- (2011) Rosario Z. Capeding et al. VACCINE
- From research to phase III: Preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine
- (2011) Bruno Guy et al. VACCINE
- A Novel Tetravalent Dengue Vaccine Is Well Tolerated and Immunogenic against All 4 Serotypes inFlavivirus‐Naive Adults
- (2010) Dennis Morrison et al. JOURNAL OF INFECTIOUS DISEASES
- Evaluation of diagnostic tests: dengue
- (2010) Rosanna W. Peeling et al. NATURE REVIEWS MICROBIOLOGY
- Live-attenuated Tetravalent Dengue Vaccine in Dengue-naïve Children, Adolescents, and Adults in Mexico City
- (2010) Jorge Poo et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Immunogenicity of sanofi pasteur tetravalent dengue vaccine
- (2009) Bruno Guy JOURNAL OF CLINICAL VIROLOGY
- Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses
- (2009) Bruno Guy et al. VACCINE
- Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects
- (2008) Bruno Guy et al. VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started